Immunohistochemistry was performed on a glioma tumor array (US Biomax, Inc, Rockville, MD, USA), using a specific anti-SETD8 antibody.
To perform immunofluorescence, cells were spotted on cover glass and treated with DMSO or UNC0379 or with siRNAs for 48 h. After treatment, cells were processed as described [20 (link)]. For details, see also the “
Immunoblot analyses of glioblastoma cells were performed upon chemical and genetic inhibition of SETD8. After 48 h of treatment, cells were collected and lysed. Lysis buffer was 0.1% NP40-PBS, plus phosSTOP and Complete Protease inhibitor (Roche Life Science, Penzberg, Germany). Cell lysates were put on ice for 10 min and centrifuged twice at 14,000 × g for 10 min. Supernatants were collected and protein lysates were separated on SDS/PAGE and blotted. Western blots were repeated three times. Full and uncropped western blots are uploaded in the “